Antimicrobial susceptibility of aerobic microorganisms isolated from intraabdominal infections in pediatric patients in Poland

Medical Science Monitor

Volumn 11, Issue 5, 2005, Pages

  Dzierzanowska Fangrat, Katarzyna ^a   Semczuk, Katarzyna ^a   Łopaciuk, Urszula ^a   Kurlenda, Julianna ^b   Małafiej, Eugeniusz ^c   Puacz, Elzbieta ^d   Stalmaska Dworak, Ewa ^e   Dzierzanowska, Danuta ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b District Hospital   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^d MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cephalosporins; Children; ES L; Piperacillin tazobactam

Indexed keywords

BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; AEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; POLAND; PSEUDOMONAS AERUGINOSA;

ABDOMEN; ADOLESCENT; BACTERIA, AEROBIC; BACTERIAL INFECTIONS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; POLAND; PSEUDOMONAS AERUGINOSA;

EID: 20344369570     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Livermore DM: The threat from the pink corner. Ann Med, 2003; 35: 226-34
2. Sitges-Serra A, Lopez MJ, Girvent R et al: Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg, 2002; 89: 361-67
3. Dancer SJ: The problem with cephalosporins. J Antimicrob Chemother, 2001; 48: 403-78
4. Strehl E, Kees F: Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use. Drugs, 2000; 59(Suppl.3): 9-18
5. Leibovici L, Berger R, Gruenwald T et al: Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. J Antimicrob Chemother, 2001; 48: 535-40
6. Paterson DL, Ko WC, Von Gottberg A et al: International prospective study of Klebsiella pneumoniae bacteriemia: implications of expended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med, 2004; 6: 26-32
7. Van Belkum A, Goessens W, van der Schee C et al: Rapid emergence of ciprofloxacin-resistant Enterobacteriacae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis, 2001; 7: 862-71
8. Canton R, Coque TM, Baquero F: Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis, 2003; 16: 315-25
9. Goosens H: Susceptibility of multi-drug resistant Pseudomonas aeruginosa in intensive care units: results from European MYSTIC study group. Clin Microbiol Infect, 2003; 9: 980-83
10. Lee SO, Kim NJ, Choi SH et al: Risk factors for acquisition of imipenem-resistant Acinetobacter baumanii: a case-control study. Antimicrob Agents Chemother, 2004; 48: 224-28
11. Wacha H, Hau T, Dittmer R, Ohmann C: Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langebecks Arch Surg, 1999; 384: 24-32
12. Sefton AM: Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs, 2002; 62: 557-66
13. Livermore DM: β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev, 1995; 8: 557-84
14. Bush K: Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis, 1996; 15: 361-64
15. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995; 39: 1211-33
16. Piroth L, Aube H, Doise JM, Vincent-Martin M: Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis, 1998; 27: 76-80
17. Flidel-Rimon O, Friedman S, Gradstein S et al: Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy. Acta Pediatr, 2003; 92: 1205-7
18. Bantar C, Vesco E, Heft C et al: Replacement of broad spectrum cephalosporins by piperacillin-tazobactam: impact on sustained rates of bacterial resistance. Antimicrob Agents Chemother, 2004; 48: 392-95
19. National Committee for Clinical Laboratory standards: Performance standards for antimicrobial susceptibility testing: eleventh informational supplement. M100-S11. Wayne. PA: NCCLS: 2001
20. Sirot J: Detection of extended-spectrum plasmid-mediated β-lactamase by disk diffusion. Clin Microbiol Infect, 1996; 2(Suppl.1), 35
21. Tomayko JF, Zscheck KK, Singh KV, Murray BE: Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis. Antimicrob Agents Chemother, 1996; 40: 1170-74
22. McAlister T, George N, Faoagali J, Bell J: Isolation of beta-lactamase-positive vancomycin resistant Enterococcus faecalis; first case in Australia. Commun Dis Intell, 1999; 23: 237-39 (Abstract)
23. Winokur PL, Canton R, Casellas JM, Legakis M: Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the western Pacific region. Clin Infect Dis, 2001; 32(Suppl.2): S94-103
24. Sekowska A, Janicka G, Klyszejko C et al: Resistance of Klebsiella pneumoniae strains producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics. Med Sci Monit. 2002; 8: 100-4
25. Borer A, Gilad J, Menashe G et al: Extended-spectrum beta-lactamase- producing Enterobacteriaceae strains in community-acquired bacteriemia in Southern Israel. Med Sci Monit, 2002; 8: 44-47
26. Sirot DL, Goldstein FW, Soussy CJ et al: Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother, 1992; 36: 1677-81
27. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis, 1996; 23: 118-24
28. Bauernfeind A, Grimm H, Schweighart S: A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection, 1990; 18: 284-88
29. Baraniak A, Fiett J, Sulikowska A et al: Countrywide spread of CTX-M-3 extended spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother, 2002; 46: 151-59